$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 3.26 | 12,500 | 40,750 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 3.26 | 12,500 | 40,750 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.84 | 12,500 | 35,500 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.84 | 12,500 | 35,500 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.74 | 12,500 | 34,250 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.74 | 12,500 | 34,250 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.74 | 12,500 | 34,250 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 2.74 | 12,500 | 34,250 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.50 | 12,500 | 18,750 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.50 | 12,500 | 18,750 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.50 | 12,500 | 18,750 | 12,500 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.50 | 12,500 | 18,750 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.36 | 10,000 | 13,600 | 10,000 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 1.36 | 10,000 | 13,600 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 1.50 | 18,750 | 28,125 | 18,750 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 1.36 | 25,000 | 34,000 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.60 | 25,000 | 15,000 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 55.08 | 1,800 | 99,144 | 1,086,185 | 1.1 M to 1.1 M (-0.17 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 54.24 | 19,654 | 1,066,033 | 1,087,985 | 1.1 M to 1.1 M (-1.77 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 53.56 | 30,046 | 1,609,264 | 1,107,639 | 1.1 M to 1.1 M (-2.64 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 1.50 | 18,750 | 28,125 | 1,137,685 | 1.1 M to 1.1 M (+1.68 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 1.36 | 25,000 | 34,000 | 1,118,935 | 1.1 M to 1.1 M (+2.29 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.60 | 25,000 | 15,000 | 1,093,935 | 1.1 M to 1.1 M (+2.34 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 1.50 | 10,000 | 15,000 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 1.36 | 12,500 | 17,000 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.60 | 7,500 | 4,500 | 0 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.60 | 5,000 | 3,000 | 7,500 | |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 1.50 | 10,000 | 15,000 | 62,200 | 52.2 K to 62.2 K (+19.16 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 52.43 | 11,264 | 590,572 | 52,200 | 63.5 K to 52.2 K (-17.75 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 51.50 | 11,236 | 578,654 | 63,464 | 74.7 K to 63.5 K (-15.04 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 1.50 | 12,500 | 18,750 | 74,700 | 62.2 K to 74.7 K (+20.10 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 1.36 | 12,500 | 17,000 | 62,200 | 49.7 K to 62.2 K (+25.15 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 52.63 | 2,600 | 136,838 | 49,700 | 52.3 K to 49.7 K (-4.97 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 52.01 | 5,725 | 297,757 | 52,300 | 58 K to 52.3 K (-9.87 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 50.93 | 4,282 | 218,082 | 58,025 | 62.3 K to 58 K (-6.87 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 49.88 | 9,893 | 493,463 | 62,307 | 72.2 K to 62.3 K (-13.70 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.60 | 7,500 | 4,500 | 72,200 | 64.7 K to 72.2 K (+11.59 %) |
| Dec 15 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.60 | 5,000 | 3,000 | 64,700 | 59.7 K to 64.7 K (+8.38 %) |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 5,272 | 0 | 5,272 | |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 56.90 | 22,230 | 1,264,887 | 22,230 | |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 54.80 | 22,700 | 1,243,960 | 1,191,156 | 1.2 M to 1.2 M (-1.87 %) |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 53.78 | 24,925 | 1,340,467 | 1,213,856 | 1.2 M to 1.2 M (-2.01 %) |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 52.15 | 15,075 | 786,161 | 1,238,781 | 1.3 M to 1.2 M (-1.20 %) |
| Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 55.96 | 30,000 | 1,678,800 | 1,253,856 | 1.3 M to 1.3 M (-2.34 %) |
| Nov 27 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 55.00 | 5,000 | 275,000 | 59,700 | 64.7 K to 59.7 K (-7.73 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 262 | 0 | 628,633 | 628.4 K to 628.6 K (+0.04 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 252 | 0 | 3,078 | 2.8 K to 3.1 K (+8.92 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 268 | 0 | 18,722 | 18.5 K to 18.7 K (+1.45 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 265 | 0 | 15,482 | 15.2 K to 15.5 K (+1.74 %) |
| Oct 02 2015 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 93 | 0 | 1,296 | 1.2 K to 1.3 K (+7.73 %) |
| Sep 11 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Option Exercise | M | 1.36 | 12,500 | 17,000 | 0 | |
| Sep 11 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Sell | S | 30.30 | 200 | 6,060 | 197,823 | 198 K to 197.8 K (-0.10 %) |
| Sep 11 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Sell | S | 30.30 | 10,000 | 303,000 | 198,023 | 208 K to 198 K (-4.81 %) |
| Sep 11 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Buy | M | 1.36 | 12,500 | 17,000 | 295,000 | 282.5 K to 295 K (+4.42 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 316 | 0 | 2,826 | 2.5 K to 2.8 K (+12.59 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 328 | 0 | 628,371 | 628 K to 628.4 K (+0.05 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 117 | 0 | 1,203 | 1.1 K to 1.2 K (+10.77 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 332 | 0 | 15,217 | 14.9 K to 15.2 K (+2.23 %) |
| Jul 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 336 | 0 | 18,454 | 18.1 K to 18.5 K (+1.85 %) |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 22 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
| Jun 09 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 26.84 | 25,000 | 671,000 | 126,500 | 151.5 K to 126.5 K (-16.50 %) |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 1.50 | 10,000 | 15,000 | 0 | |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 1.36 | 12,500 | 17,000 | 0 | |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 0.60 | 12,500 | 7,500 | 0 | |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 1.50 | 10,000 | 15,000 | 151,500 | 141.5 K to 151.5 K (+7.07 %) |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 1.50 | 12,500 | 18,750 | 141,500 | 129 K to 141.5 K (+9.69 %) |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 1.36 | 12,500 | 17,000 | 129,000 | 116.5 K to 129 K (+10.73 %) |
| May 20 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 0.60 | 12,500 | 7,500 | 116,500 | 104 K to 116.5 K (+12.02 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 444 | 0 | 14,885 | 14.4 K to 14.9 K (+3.07 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Option Exercise | M | 0.60 | 12,500 | 7,500 | 0 | |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Buy | M | 0.60 | 12,500 | 7,500 | 282,500 | 270 K to 282.5 K (+4.63 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 157 | 0 | 1,086 | 929 to 1.1 K (+16.90 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.36 | 10,000 | 13,600 | 0 | |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 0.96 | 5,000 | 4,800 | 0 | |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.36 | 10,000 | 13,600 | 18,118 | 8.1 K to 18.1 K (+123.18 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 0.96 | 5,000 | 4,800 | 8,118 | 3.1 K to 8.1 K (+160.36 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 450 | 0 | 3,118 | 2.7 K to 3.1 K (+16.87 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 423 | 0 | 2,510 | 2.1 K to 2.5 K (+20.27 %) |
| Apr 02 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 439 | 0 | 628,043 | 627.6 K to 628 K (+0.07 %) |
| Mar 12 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 24.00 | 625,000 | 15,000,000 | 627,604 | 2.6 K to 627.6 K (+24,001.54 %) |
| Mar 12 2015 | ITCI | Intra-Cellular The ... | Sosland Morton I. | 10% Owner | Buy | P | 24.00 | 250,000 | 6,000,000 | 2,198,554 | 1.9 M to 2.2 M (+12.83 %) |
| Jan 16 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Sell | S | 19.00 | 5,000 | 95,000 | 270,000 | 275 K to 270 K (-1.82 %) |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Sanchez Juan F. | VP, Corp. Communica ... | Option Exercise | A | 17.57 | 30,050 | 527,979 | 30,050 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | A | 17.57 | 12,020 | 211,191 | 12,020 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Fienberg Allen A. | VP of Business Deve ... | Option Exercise | A | 17.57 | 40,066 | 703,960 | 40,066 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 17.57 | 72,120 | 1,267,148 | 72,120 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 17.57 | 72,120 | 1,267,148 | 72,120 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 17.57 | 88,146 | 1,548,725 | 88,146 | |
| Jan 06 2015 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 17.57 | 228,380 | 4,012,637 | 228,380 | |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 212 | 0 | 929 | 717 to 929 (+29.57 %) |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 601 | 0 | 14,441 | 13.8 K to 14.4 K (+4.34 %) |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 609 | 0 | 2,668 | 2.1 K to 2.7 K (+29.58 %) |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 508 | 0 | 2,087 | 1.6 K to 2.1 K (+32.17 %) |
| Jan 05 2015 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 594 | 0 | 2,604 | 2 K to 2.6 K (+29.55 %) |
| Dec 10 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 16.52 | 11,535 | 190,558 | 64,700 | 76.2 K to 64.7 K (-15.13 %) |
| Dec 10 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 16.91 | 10,965 | 185,418 | 76,235 | 87.2 K to 76.2 K (-12.57 %) |
| Dec 03 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.50 | 37,200 | 18,600 | 0 | |
| Dec 03 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.50 | 37,200 | 18,600 | 87,200 | 50 K to 87.2 K (+74.40 %) |
| Dec 03 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 14.75 | 1,422 | 20,975 | 3,596,205 | 3.6 M to 3.6 M (+0.04 %) |
| Dec 03 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 14.75 | 1,422 | 20,975 | 3,596,205 | 3.6 M to 3.6 M (+0.04 %) |
| Dec 03 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 14.75 | 1,422 | 20,975 | 3,596,205 | 3.6 M to 3.6 M (+0.04 %) |
| Nov 21 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 14.25 | 1,034 | 14,735 | 3,559,783 | 3.6 M to 3.6 M (+0.03 %) |
| Nov 21 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 14.25 | 1,034 | 14,735 | 3,559,783 | 3.6 M to 3.6 M (+0.03 %) |
| Nov 21 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 14.25 | 1,034 | 14,735 | 3,559,783 | 3.6 M to 3.6 M (+0.03 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 14.23 | 3,531 | 50,246 | 3,558,749 | 3.6 M to 3.6 M (+0.10 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.07 | 133 | 2,004 | 3,555,218 | 3.6 M to 3.6 M (0.00 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 14.23 | 3,531 | 50,246 | 3,558,749 | 3.6 M to 3.6 M (+0.10 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 15.07 | 133 | 2,004 | 3,555,218 | 3.6 M to 3.6 M (0.00 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 14.23 | 3,531 | 50,246 | 3,558,749 | 3.6 M to 3.6 M (+0.10 %) |
| Nov 18 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 15.07 | 133 | 2,004 | 3,555,218 | 3.6 M to 3.6 M (0.00 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.12 | 2,200 | 33,264 | 3,555,085 | 3.6 M to 3.6 M (+0.06 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.23 | 5,000 | 76,150 | 3,552,885 | 3.5 M to 3.6 M (+0.14 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.55 | 5,000 | 77,750 | 3,547,885 | 3.5 M to 3.5 M (+0.14 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 15.12 | 2,200 | 33,264 | 3,555,085 | 3.6 M to 3.6 M (+0.06 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 15.23 | 5,000 | 76,150 | 3,552,885 | 3.5 M to 3.6 M (+0.14 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 15.55 | 5,000 | 77,750 | 3,547,885 | 3.5 M to 3.5 M (+0.14 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 15.12 | 2,200 | 33,264 | 3,555,085 | 3.6 M to 3.6 M (+0.06 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 15.23 | 5,000 | 76,150 | 3,552,885 | 3.5 M to 3.6 M (+0.14 %) |
| Nov 13 2014 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 15.55 | 5,000 | 77,750 | 3,547,885 | 3.5 M to 3.5 M (+0.14 %) |
| Nov 06 2014 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | P | 15.47 | 13,000 | 201,110 | 20,000 | 7 K to 20 K (+185.71 %) |
| Nov 06 2014 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | P | 15.21 | 7,000 | 106,470 | 7,000 | 0 to 7 K |
| Oct 17 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 5,152 | 77,280 | 104,000 | 109.2 K to 104 K (-4.72 %) |
| Oct 15 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 2,004 | 30,060 | 109,152 | 111.2 K to 109.2 K (-1.80 %) |
| Oct 15 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 1,600 | 24,000 | 111,156 | 112.8 K to 111.2 K (-1.42 %) |
| Oct 10 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 4,745 | 71,175 | 112,756 | 117.5 K to 112.8 K (-4.04 %) |
| Oct 07 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 636 | 9,540 | 117,501 | 118.1 K to 117.5 K (-0.54 %) |
| Oct 07 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 15,863 | 237,945 | 118,137 | 134 K to 118.1 K (-11.84 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 273 | 0 | 717 | 444 to 717 (+61.49 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 774 | 0 | 13,840 | 13.1 K to 13.8 K (+5.92 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 784 | 0 | 2,059 | 1.3 K to 2.1 K (+61.49 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 601 | 0 | 1,579 | 978 to 1.6 K (+61.45 %) |
| Oct 02 2014 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 765 | 0 | 2,010 | 1.2 K to 2 K (+61.45 %) |
| Sep 17 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Sell | S | 15.00 | 5,000 | 75,000 | 134,000 | 139 K to 134 K (-3.60 %) |
| Sep 10 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.50 | 300 | 150 | 37,200 | |
| Sep 10 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 15.00 | 300 | 4,500 | 50,000 | 50.3 K to 50 K (-0.60 %) |
| Sep 10 2014 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.50 | 300 | 150 | 50,300 | 50 K to 50.3 K (+0.60 %) |
| Jul 31 2014 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 13.86 | 100,000 | 1,386,000 | 100,000 | |
| Jul 22 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Option Exercise | M | 0.50 | 37,500 | 18,750 | 0 | |
| Jul 22 2014 | ITCI | Intra-Cellular The ... | Wennogle Lawrence P. | Vice President, Dru ... | Buy | M | 0.50 | 37,500 | 18,750 | 139,000 | 101.5 K to 139 K (+36.95 %) |
| Jul 10 2014 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Sell | S | 6.35 | 15,742 | 100,006 | 0 | 15.7 K to 0 (-100.00 %) |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 444 | 0 | 444 | 0 to 444 |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 16.86 | 20,000 | 337,200 | 20,000 | |
| Jul 02 2014 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 1,260 | 0 | 13,066 | 11.8 K to 13.1 K (+10.67 %) |